Dr. Halat is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5339 Odonovan Dr
Baton Rouge, LA 70808Phone+1 225-766-4999Fax+1 225-767-4702
Summary
- Dr. Shams Halat is a pathologist in New Orleans, LA and is affiliated with Tulane Health System. She received her medical degree from American University of Beirut Faculty of Medicine and has been in practice 16 years. She specializes in cytopathology, genitourinary pathology, anatomic pathology, and clinical pathology.
Education & Training
- Indiana University School of MedicineFellowship, Genitourinary pathology, 2009 - 2011
- University of Pennsylvania Health SystemFellowship, Cytopathology, 2008 - 2009
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Pathology-Anatomic and Clinical, 2006 - 2008
- Tulane UniversityResidency, Pathology-Anatomic and Clinical, 2004 - 2006
- Case Western Reserve University/University Hospitals Cleveland Medical CenterInternship, Internal Medicine, 2003 - 2004
- American University of Beirut Faculty of MedicineClass of 2001
Certifications & Licensure
- LA State Medical License 2010 - 2025
- PA State Medical License 2008 - 2009
- OH State Medical License 2003 - 2008
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Cytopathology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 72 citationsMultilocular cystic renal cell carcinoma is a subtype of clear cell renal cell carcinomaShams Halat, John N. Eble, David J. Grignon, Antonio Lopez-Beltran, Rodolfo Montironi
Modern Pathology. 2010-03-26 - 6 citationsAdvanced papillary renal cell carcinoma: Epidemiology, genomic drivers, current therapies, and ongoing trials.Patrick L Sweeney, Albert Jang, Shams K Halat, Sumanta K Pal, Pedro C Barata
Cancer Treatment and Research Communications. 2022-01-01 - 8 citationsMicroRNA-Based Risk Score for Predicting Tumor Progression Following Radioactive Iodine Ablation in Well-Differentiated Thyroid Cancer Patients: A Propensity-Score Mat...Eman A. Toraih, Manal S. Fawzy, Mohammad H. Hussein, Mohamad M. EL-Labban, Emmanuelle Ruiz
Cancers. 2021-09-16
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: